Competitive Technologies, Inc. (AMEX: CTT) announced that it had filed a complaint against Carolina Liquid Chemistries Corporation ("Carolina Liquid") of Brea, California, alleging patent infringement of CTT's U.S. Patent Number 4,940,658 covering homocysteine assays. The complaint was filed in the United States District Court for the District of Colorado. In the complaint, CTT seeks monetary damages, punitive damages, attorneys' fees, court costs and other remuneration at the option of the court. The homocysteine patent was derived from discoveries made by CTT's clients Drs. Robert Allen and Sally Stabler from the University of Colorado and the late Dr. John Lindenbaum from Columbia University. "The filing of this complaint is part of our comprehensive and ongoing monitoring program to protect the patent rights of ourselves, our clients, and our current homocysteine licensees," said Aris D. Despo, CTT's Senior Vice President, Life Sciences. "While we believe that we already have licensed the majority of laboratories, distributors and other users of homocysteine assay tests in the Unites States, we continue our diligence in seeking those who use or sell tests without a license."

Posted by GEN-ERIC at 12:01:40 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/374

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)